ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure

  1. Wieneke Dijk
  2. Markus Heine
  3. Laurent Vergnes
  4. Mariëtte R Boon
  5. Gert Schaart
  6. Matthijs KC Hesselink
  7. Karen Reue
  8. Wouter D van Marken Lichtenbelt
  9. Gunilla Olivecrona
  10. Patrick CN Rensen
  11. Joerg Heeren
  12. Sander Kersten  Is a corresponding author
  1. Wageningen University, Netherlands
  2. University of Hamburg, Germany
  3. University of California, Los Angeles, United States
  4. Leiden University, Netherlands
  5. Maastricht University, Netherlands
  6. European Society for Medical Oncology, Netherlands
  7. Umeå University, Sweden
  8. Leiden University Medical Center, Netherlands

Abstract

Brown adipose tissue (BAT) activation via cold exposure is increasingly scrutinized as a potential approach to ameliorate cardio-metabolic risk. Transition to cold temperatures requires changes in the partitioning of energy substrates, re-routing fatty acids to BAT to fuel non-shivering thermogenesis. However, the mechanisms behind the redistribution of energy substrates to BAT remain largely unknown. Angiopoietin-like 4 (ANGPTL4), a protein that inhibits lipoprotein lipase (LPL) activity, is highly expressed in BAT. Here, we demonstrate that ANGPTL4 is part of a shuttling mechanism that directs fatty acids derived from circulating triglyceride-rich lipoproteins to BAT during cold. Specifically, we show that cold markedly down-regulates ANGPTL4 in BAT, likely via activation of AMPK, enhancing LPL activity and uptake of plasma triglyceride-derived fatty acids. In contrast, cold up-regulates ANGPTL4 in WAT, abolishing a cold-induced increase in LPL activity. Together, our data indicate that ANGPTL4 is an important regulator of plasma lipid partitioning during sustained cold.

Article and author information

Author details

  1. Wieneke Dijk

    Nutrition, Metabolism and Genomics group, Division of Human Nutrition, Wageningen University, Wageningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  2. Markus Heine

    Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Laurent Vergnes

    Department of Human Genetics, David Geffen School of Medicine, Molecular Biology Institute, University of California, Los Angeles, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Mariëtte R Boon

    Department of Medicine, Division of Endocrinology, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden University, Leiden, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  5. Gert Schaart

    Department of Human Movement Sciences, Maastricht University, Maastricht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  6. Matthijs KC Hesselink

    Department of Human Movement Sciences, Maastricht University, Maastricht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  7. Karen Reue

    Department of Human Genetics, David Geffen School of Medicine, Molecular Biology Institute, University of California, Los Angeles, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Wouter D van Marken Lichtenbelt

    Department of Human Biology, Maastricht University Medical Centre, European Society for Medical Oncology, Maastricht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  9. Gunilla Olivecrona

    Department of Medical Biosciences/Physiological Chemistry, Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  10. Patrick CN Rensen

    Department of Medicine, Division of Endocrinology, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  11. Joerg Heeren

    Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Sander Kersten

    Nutrition, Metabolism and Genomics group, Division of Human Nutrition, Wageningen University, Wageningen, Netherlands
    For correspondence
    sander.kersten@wur.nl
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Michael Czech, University of Massachusetts Medical School, United States

Ethics

Animal experimentation: This study was performed in accordance with Directive 2010/63/EU from the European Union. All of the animals were handled according to protocols approved by the Animal Ethics Committees of Wageningen University and Hamburg University (2013007.d, 2013100.b and 34/12).

Human subjects: All subjects signed an informed consent for the study protocol, which was approved by the institutional review board of Maastricht University Medical Centre.

Version history

  1. Received: April 29, 2015
  2. Accepted: October 16, 2015
  3. Accepted Manuscript published: October 17, 2015 (version 1)
  4. Version of Record published: December 30, 2015 (version 2)

Copyright

© 2015, Dijk et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,021
    views
  • 1,013
    downloads
  • 103
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Wieneke Dijk
  2. Markus Heine
  3. Laurent Vergnes
  4. Mariëtte R Boon
  5. Gert Schaart
  6. Matthijs KC Hesselink
  7. Karen Reue
  8. Wouter D van Marken Lichtenbelt
  9. Gunilla Olivecrona
  10. Patrick CN Rensen
  11. Joerg Heeren
  12. Sander Kersten
(2015)
ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure
eLife 4:e08428.
https://doi.org/10.7554/eLife.08428

Share this article

https://doi.org/10.7554/eLife.08428

Further reading

    1. Stem Cells and Regenerative Medicine
    Magali Seguret, Patricia Davidson ... Jean-Sébastien Hulot
    Research Article

    We developed a 96-well plate assay which allows fast, reproducible, and high-throughput generation of 3D cardiac rings around a deformable optically transparent hydrogel (polyethylene glycol [PEG]) pillar of known stiffness. Human induced pluripotent stem cell-derived cardiomyocytes, mixed with normal human adult dermal fibroblasts in an optimized 3:1 ratio, self-organized to form ring-shaped cardiac constructs. Immunostaining showed that the fibroblasts form a basal layer in contact with the glass, stabilizing the muscular fiber above. Tissues started contracting around the pillar at D1 and their fractional shortening increased until D7, reaching a plateau at 25±1%, that was maintained up to 14 days. The average stress, calculated from the compaction of the central pillar during contractions, was 1.4±0.4 mN/mm2. The cardiac constructs recapitulated expected inotropic responses to calcium and various drugs (isoproterenol, verapamil) as well as the arrhythmogenic effects of dofetilide. This versatile high-throughput assay allows multiple in situ mechanical and structural readouts.

    1. Stem Cells and Regenerative Medicine
    Shintaro Watanuki, Hiroshi Kobayashi ... Keiyo Takubo
    Research Article

    Metabolic pathways are plastic and rapidly change in response to stress or perturbation. Current metabolic profiling techniques require lysis of many cells, complicating the tracking of metabolic changes over time after stress in rare cells such as hematopoietic stem cells (HSCs). Here, we aimed to identify the key metabolic enzymes that define differences in glycolytic metabolism between steady-state and stress conditions in murine HSCs and elucidate their regulatory mechanisms. Through quantitative 13C metabolic flux analysis of glucose metabolism using high-sensitivity glucose tracing and mathematical modeling, we found that HSCs activate the glycolytic rate-limiting enzyme phosphofructokinase (PFK) during proliferation and oxidative phosphorylation (OXPHOS) inhibition. Real-time measurement of ATP levels in single HSCs demonstrated that proliferative stress or OXPHOS inhibition led to accelerated glycolysis via increased activity of PFKFB3, the enzyme regulating an allosteric PFK activator, within seconds to meet ATP requirements. Furthermore, varying stresses differentially activated PFKFB3 via PRMT1-dependent methylation during proliferative stress and via AMPK-dependent phosphorylation during OXPHOS inhibition. Overexpression of Pfkfb3 induced HSC proliferation and promoted differentiated cell production, whereas inhibition or loss of Pfkfb3 suppressed them. This study reveals the flexible and multilayered regulation of HSC glycolytic metabolism to sustain hematopoiesis under stress and provides techniques to better understand the physiological metabolism of rare hematopoietic cells.